Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025.Fourth positive DSMB ...
Hosted on MSN13d
Alltrna plans to tackle rare diseases using tRNA-based therapiesUS-based biotechnology company Alltrna is developing transfer RNA (tRNA)-based therapies that aim to offer a broad solution ...
This new article published in Genes & Diseases highlights the critical role of tRNA-derived small RNAs (tsRNAs) in digestive ...
This new article published in Genes & Diseases highlights the critical role of tRNA-derived small RNAs (tsRNAs) in digestive ...
Peer-reviewed publication validates efzofitimod’s unique anti-inflammatory mechanism of action on macrophages through neuropilin-2 (NRP2) ...
Hosted on MSN2mon
A passive resistance phenomenon: Marine bacteria use low tRNA levels to fend off virusesThe Technion researchers' study describes an evolutionary scenario where protection arises from a reduced level of tRNA (transfer RNA), a molecule critical for gene translation. "Studies on ...
The pioneering research of UC Santa Cruz’s Upasna Sharma to determine how a father’s life experiences and environment can ...
Transfer ribonucleic acid (tRNA) is a type of RNA molecule that helps decode a messenger RNA (mRNA) sequence into a protein. tRNAs function at specific sites in the ribosome during translation ...
No safety concerns identified by independent data and safety monitoring board (DSMB), which recommends continuation of study ...
SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company ...
The pioneering research of UC Santa Cruz's Upasna Sharma to determine how a father's life experiences and environment can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback